The Effect of BSA-Based Curcumin Nanoparticles on Memory and Hippocampal MMP-2, MMP-9, and MAPKs in Adult Mice

Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818. https://doi.org/10.1021/mp700113r Aniesrani Delfiya DS, Thangavel K, Amirtham D (2016) Preparation of curcumin loaded egg albumin nanoparticles using acetone and optimization of desolvation process. Protein J 35:124–135. https://doi.org/10.1007/s10930-016-9652-3 Bach DR, Tzovara A, Vunder J (2017) Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline. Mol Psychiatry. https://doi.org/10.1038/mp.2017.65 Baum L et al (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110–113. https://doi.org/10.1097/jcp.0b013e318160862c Brkic M, Balusu S, Libert C, Vandenbroucke RE (2015) Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediat Inflamm 2015:620581. https://doi.org/10.1155/2015/620581 Cox KH, Pipingas A, Scholey AB (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol (Oxford, England) 29:642–651. https://doi.org/10.1177/0269881114552744 Duits FH et al (2015) Matrix metalloproteinases in Alzheimer’s disease and concurrent cerebral microbleeds. J Alzheimer’s Dis 48:711–720. https://doi.org/10.3233/jad-143186 Feld M, Krawczyk MC, Sol Fustinana M, Blake MG, Baratti CM, Romano A, Boccia MM (2014) Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer’s disease. J Alzheimer’s Dis 40:69–82. https://doi.org/10.3233/jad-131076 Fujimoto M et al (2008) Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 28:1674–1685 Ghasemi R, Zarifkar A, Rastegar K, maghsoudi N, Moosavi M (2014a) Insulin protects against Abeta-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption. Neuropharmacology 85:113–120. https://doi.org/10.1016/j.neuropharm.2014.01.036 Ghasemi R, Zarifkar A, Rastegar K, Maghsoudi N, Moosavi M (2014b) Repeated intra-hippocampal injection of beta-amyloid 25-35 induces a reproducible impairment of learning and memory: considering caspase-3 and MAPKs activity. Eur J Pharmacol 726:33–40. https://doi.org/10.1016/j.ejphar.2013.11.034 Giese KP, Mizuno K (2013) The roles of protein kinases in learning and memory learning & memory. Learn Mem 20:540–552. https://doi.org/10.1101/lm.028449.112 Giovannini MG (2006) The role of the extracellular signal-regulated kinase pathway in memory encoding. Rev Neurosci 17:619–634 Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58:2095–2099. https://doi.org/10.1021/jf9024807 Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y (2007) Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101:566–576. https://doi.org/10.1111/j.1471-4159.2006.04393.x Jithan AV, Madhavi K, Madhavi M, Prabhakar K (2011) Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig 1:119–125. https://doi.org/10.4103/2230-973X.82432 John TA, Vogel SM, Tiruppathi C, Malik AB, Minshall RD (2003) Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 284:L187–L196. https://doi.org/10.1152/ajplung.00152.2002 Kim TH et al (2011) Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–291. https://doi.org/10.1016/j.ijpharm.2010.10.041 Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J (2017) Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer’s disease. eNeuro 4. https://doi.org/10.1523/eneuro.0149-16.2017 Li L, Braiteh FS, Kurzrock R (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322–1331. https://doi.org/10.1002/cncr.21300 Liu D, Wang Z, Gao Z, Xie K, Zhang Q, Jiang H, Pang Q (2014) Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress. Behav Brain Res 271:116–121. https://doi.org/10.1016/j.bbr.2014.05.068 Lorenzl S et al (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease. Neurochem Int 43:191–196 Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, Eckert A (2003) Neurotoxic mechanisms caused by the Alzheimer’s disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278:28294–28302. https://doi.org/10.1074/jbc.M212265200 Martisova E, Aisa B, Guerenu G, Ramirez MJ (2013) Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer’s disease in adult male rats. Curr Alzheimer Res 10:420–432 Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease. Neurology 56:127–129 Meighan SE et al (2006) Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 96:1227–1241. https://doi.org/10.1111/j.1471-4159.2005.03565.x Minshall RD, Tiruppathi C, Vogel SM, Malik AB (2002) Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 117:105–112. https://doi.org/10.1007/s00418-001-0367-x Moosavi M, Khales GY, Abbasi L, Zarifkar A, Rastegar K (2012) Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology 62:2018–2023. https://doi.org/10.1016/j.neuropharm.2011.12.031 Moosavi M, Abbasi L, Zarifkar A, Rastegar K (2014) The role of nitric oxide in spatial memory stages, hippocampal ERK and CaMKII phosphorylation. Pharmacol Biochem Behav 122:164–172. https://doi.org/10.1016/j.pbb.2014.03.021 Moosavi M, SoukhakLari R, Moezi L, Pirsalami F (2017) Scopolamine-induced passive avoidance memory retrieval deficit is accompanied with hippocampal MMP2, MMP-9 and MAPKs alteration. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2017.12.007 Natarajan R, Harding JW, Wright JW (2013) A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats. J Exp Neurosci 7:1–14. https://doi.org/10.4137/jen.s11381 Ng T-P, Chiam P-C, Lee T, Chua H-C, Lim L, Kua E-H (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164:898–906. https://doi.org/10.1093/aje/kwj267 Perry G et al (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411–2415 Rein MJ, Renouf M, Cruz-Hernandez C, Actis-Goretta L, Thakkar SK, da Silva Pinto M (2013) Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br J Clin Pharmacol 75:588–602. https://doi.org/10.1111/j.1365-2125.2012.04425.x Ringman JM et al (2012) Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4:43. https://doi.org/10.1186/alzrt146 Sahara N, Murayama M, Lee B, Park JM, Lagalwar S, Binder LI, Takashima A (2008) Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation. Eur J Neurosci 27:2897–2906. https://doi.org/10.1111/j.1460-9568.2008.06258.x Scheepens A, Tan K, Paxton JW (2010) Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr 5:75–87. https://doi.org/10.1007/s12263-009-0148-z Solas M, Aisa B, Tordera RM, Mugueta MC, Ramirez MJ (2013) Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer’s disease. Biochim Biophys Acta 1832:2332–2339. https://doi.org/10.1016/j.bbadis.2013.09.013 Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E (2006) Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65:142–151. https://doi.org/10.1097/01.jnen.0000199599.63204.6f Witkin JM et al (2013) Further evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcumin. CNS Neurol Disord Drug Targets 12:498–505 Xiong H, Zheng C, Wang J, Song J, Zhao G, Shen H, Deng Y (2013) The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. J Alzheimer’s Dis 37:623–635. https://doi.org/10.3233/jad-130584 Yarza R, Vela S, Solas M, Ramirez MJ (2015) C-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease. Front Pharmacol 6:321. https://doi.org/10.3389/fphar.2015.00321 Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502–511. https://doi.org/10.1038/35081571 Zhang L et al (2015) Curcumin improves amyloid beta-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One 10:e0131525. https://doi.org/10.1371/journal.pone.0131525 Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis. Mech Ageing Dev 123:39–46